Close
Novotech
Jabsco PureFlo 21 Single Use

Drug Research

Novartis Enters into Deal with Legend Biotech for $100 Million Upfront

Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies. The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend...

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies. The collaboration was established...

New Pharma Legislation May Cut Europe R&D Share By One-Third

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a newly published assessment, EFPIA infers that the draft proposals would further speed up the decline...

Indian Pharma Companies Enhanced Global Healthcare Access

As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes to high-quality drugs, thereby greatly elevating global access to healthcare. During his speech at the Second...

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, announced the acquisition of Tec4med Lifescience GmbH, a...

Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurmas portfolio companies

Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of development to large-scale commercialization The partnership will streamline gene to IND process to accelerate lead candidate selection and advance CMC along clinical development Multi-year...

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »